Baseline and Post-baseline Resistance Analyses of Phase 2/3 Studies of Ledipasvir/Sofosbuvir +/- RBV - Sarrazin, C; Dvory-Sobol, H; Svarovskaia, E S (Hepatology, 2014)
et al.